The mission ofthe Oncology Medical Informatics and Services (OMIS) Shared Resource is to provide centralized informatics and software support with data management and analytics services to support the Masonic Cancer Center (MCC) as well as the research projects of all of its members. OMIS develops and supports database applications to provide research data management for all clinical and basic research activities in the MCC. Services include data integration, custom reporting and data set generation, grant support, database application design, development and support, and registry creation. The OMIS Shared Resource provides a critical function not currently available through the University of Minnesota Clinical and Translational Science Institute (CTSI) or the Academic Health Center. OMIS is led by Dr. Sarah Cooley, an Assistant Professor in the Division of Hematology, Oncology, and Transplantation who also serves as the Director of Clinical Research Information (a joint appointment between the University of Minnesota CTSI and Biomedical Health Informatics program) to play a key role in helping the Academic Health Center develop system-wide processes to integrate clinical and genomic data to support translational research and clinical research and personalized medicine. The OMIS group consists of a Senior Manager and a team of 9 full-time staff including, 4 programmer/database administrators, 2 research data analysts, 1 software developer, 1 data architect, and 1 informatics project manager. OMIS provides consultation free of charge to all MCC members to help prepare the informatics resource sections for grant applications and to provide initial cost estimates for other informatics projects. In addition to supporting the administrative needs ofthe MCC, the Resource supports significant database applications used by the Translational Therapy Laboratory (MSC-LIMS), the Clinical Trials Office (OnCore), and the Transplant Biology and Therapy Research Program (BMT Database). The OMIS Resource also supports NIH-funded projects from researchers from 3 of the MCC Research Programs and projects funded by other sources in 2 additional Research Programs. The services and expertise provided by this Shared Resource are critical to the clinical research mission of the MCC.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
United States
Zip Code
Mondragon-Gonzalez, Ricardo; Perlingeiro, Rita C R (2018) Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery. Dis Model Mech 11:
Kim, J-H; Frantz, A M; Sarver, A L et al. (2018) Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers. Vet Comp Oncol 16:E176-E184
Jin, Jin; Zhang, Lin; Leng, Ethan et al. (2018) Detection of prostate cancer with multiparametric MRI utilizing the anatomic structure of the prostate. Stat Med 37:3214-3229
Pierpont, Elizabeth I; Hudock, Rebekah L; Foy, Allison M et al. (2018) Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. J Neurodev Disord 10:21
Carlson, Erik S; Upadhyaya, Pramod; Villalta, Peter W et al. (2018) Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)-1-(3-p Chem Res Toxicol 31:358-370
Lin, Lifeng; Chu, Haitao; Murad, Mohammad Hassan et al. (2018) Empirical Comparison of Publication Bias Tests in Meta-Analysis. J Gen Intern Med 33:1260-1267
Rashidi, Armin; Ebadi, Maryam; Said, Bassil et al. (2018) Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect. Am J Hematol :
Bejanyan, Nelli; Brunstein, Claudio G; Cao, Qing et al. (2018) Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD. Blood Adv 2:909-922
Bachanova, Veronika; Sarhan, Dhifaf; DeFor, Todd E et al. (2018) Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells. Cancer Immunol Immunother 67:483-494
Hupp, Meghan; Williams, Sarah; Dunnette, Brian et al. (2018) Comparison of evaluation techniques, including digital image analysis, for MYC protein expression by immunohistochemical stain in aggressive B-cell lymphomas. Hum Pathol :

Showing the most recent 10 out of 1013 publications